Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
Crossref DOI link: https://doi.org/10.1007/s40123-023-00753-6
Published Online: 2023-07-06
Published Print: 2023-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Larsen, Helene O.
Grauslund, Jakob
Vergmann, Anna S. http://orcid.org/0000-0003-0124-7542
Text and Data Mining valid from 2023-07-06
Version of Record valid from 2023-07-06
Article History
Received: 27 March 2023
Accepted: 8 June 2023
First Online: 6 July 2023